Skip to main content

Table 3 Pyrimethamine pharmacokinetic parameters (Median [IQR]) in Malian children under five with uncomplicated falciparum malaria, by treatment group

From: Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali

PARAMETERS

SP arm

SP+AQ arm

SP+AS arm

P-value

[Kruskal-Wallis]

Pyrimethamine dose (mg/kg)

1.39

(1.25-1.56)

1.44

(1.25-1.56)

1.39

(1.25-1.44)

0.46

Median Concentration day1

[IQR] (ng/mL)

259.50

[212.50-337.50]

300.50

[220.00-339.25]

274.00

[235.00-312.00]

0.55

Median Concentration day 3

[IQR] (ng/mL)

155

[127-187]

174

[132-215]

158

[119-191]

0.14

Median Concentration day 7

[IQR] (ng/mL)

56.75

[46.40-92.95]

58.75

[43.60-98.60]

59.60

[42.45-86.63]

0.85

Median AUC

[IQR] (ng/mL.day)

1307.45

[1087.59-1773.94]

1405.32

[1110.36-2016.49]

1363.76

[1193.71-1765.91]

0.46

Median VD [IQR]

(L/kg)

4.65

[3.93-6.40]

4.00

[3.03-5.43]

5.60

[4.40-7.20]

0.001

Median T1/2 [IQR]

(days)

3.26

[2.74-3.82]

2.78

[2.24-3.65]

4.02

[3.05-4.85]

0.0016

Median Clearance [IQR] (L/kg/day)

1.10

[0.80-1.38]

1.00

[0.70-1.30]

1.00

[0.80-1.20]

0.38

  1. For VD: SP VS. SP + AQ, P = 0.008; SP + AQ VS. SP + AS, P = 0.000; and SP VS. SP +AS, P = 0.030
  2. For T1/2: SP VS. SP +AQ, P = 0.046; SP + AQ VS. SP + AS, P = 0.001; and SP VS. SP + AS, P = 0.071